[BC]2

👋 We stopped publishing on this platform. Given the enthusiasm for Bluesky in the scientific community and beyond, you will now find us there at: bsky.app/profile/sib.sw… or on LinkedIn! Cheers

@BioAlps @iscb @emblebi @ELIXIREurope @LS2Switzerland @unil @EPFL_en @unige_en @UniBasel_en @ETH_en 🚀Our tutorials & workshops at the #bc2basel conference 2023 were so popular with 218 participants, we had to create a waiting list! Don't miss your chance to share your #bioinformatics expertise: bc2.ch/tutorials-work… 🗓️ Deadline to submit a tutorial/workshop: 7 January 2025

🚀 Call for tutorials & workshops! Showcase your #bioinformatics expertise at the next #bc2basel conference, 8-10 Sept. 2025. Submit a proposal for a full or half-day session! 🔗 bc2.ch/tutorials-work… 🗓️ Deadline: 7 January 2025

📢 SAVE THE DATE! Join us for the [BC]² Basel #ComputationalBiology Conference 2025: "Bioinformatics Meets AI – Shaping the Future of Data-Driven Biology!" 🗓️ Main Conference: Sept 9-10, 2025 🧑‍🏫 Tutorials & Workshops: Sept 8, 2025 👉 Stay updated at bc2.ch

Bioinformaticians of the world, it’s your time to shine! The SIB Bioinformatics Awards are now open to entries. They promote excellence, diversity & innovation in the field. Submit your best work & share with colleagues. sib.swiss/bioinformatics… #SIBawards #ComputationalBiology

@BioAlps, @iscb, @emblebi, @ELIXIREurope @LS2Switzerland @CampusBiotech @H3ABioNet @bioinfowomen @UniBasel_en @unil @unige_en @ETH_en

If you are in Switzerland on Jan 11 2024, join us for our symposium 'Cell Lines in the 21st Century' my.weezevent.com/cell-lines-in-… with an impressive list of speakers (see below)

Congratulations to Anastasia Sveshnikova, who won the first #bc2basel Artwork Prize, sponsored by @Roche. Discover her winning submission: bc2.ch/news/bc2-artwo… #Bioinformatics #Artificialintelligence

At this year’s #bc2basel, the scientific and organizational committees strived to ensure an inclusive and diverse event and provide equal opportunities for all participants. Explore the key figures and takeaways: bc2.ch/news/EDI-key-f… #EDI #inclusion #womeninscience

Thank you to all attendees and speakers as well as our sponsors for making this conference a special one. Stay tuned at bc2.ch and follow @Bc2conference for updates on the next conference, set for September 8-11, 2025! #bioinformatics

Over 500 gathered in Basel for this year’s @bc2conference! Discover the highlights of this exceptional edition of the event with a stimulating scientific programme celebrating 20 years since it was first held: tinyurl.com/ykvcyx27 #bc2basel #ComputationalBiology #genomics

We hope you all enjoyed this 20th anniversary edition of the Basel #ComputationalBiology Conference. It was great to celebrate this milestone with a fantastic lineup. Stay tuned for updates on the next edition, scheduled for September 8-11, 2025! #Bioinformatics

Congratulations too to the winners of this year's poster prizes!

Congratulations to Anastasia Sveshnikova, who won the first BC2 Artwork Prize! Presented by Katrin Arnold, site head at @Roche, who sponsored the prize, the theme this year was "Visions of the future in bioinformatics: Imagine your work in 2043".

Having a great time at SIB BC2 in Basel! Come and visit me at my poster during the afternoon session

Cool BC2 artwork competition in comp bio, won by Anastasia Sveshnikova.

Stay tuned to also find out the winner of the Poster and @BC2Conference Artwork Prizes and hear the closing words from SIB’s Executive Director, @cdessimoz!

We have come to the last session of #BC2basel 2023 with Fabian J. Theis now presenting the closing keynote address on modelling #singlecell state and responses with #MachineLearning and #GenerativeAI Chaired by @GfellerD and @jaggakatja

A special session now on building successful #IndustryAcademia collaborations. Including insights and best practices to stimulate🇨🇭innovation with these partnerships, benefits for both sides and pioneering cases. Chaired by Madiha Derouazi and Vincent Zoete #bc2basel

Ido @IdoAmitLab talking at BC2 on single cell immunology and how to use single cell approaches for therapeutics, in particular for their new TREM2 antagonists in glioblastoma.